Sandoz AG - Company & Market Research Reports

Home /
Companies /
Sandoz AG

Sandoz is recognized as the global leader in biosimilars and generic antibiotics, dermatology and transplantation medicines. It also holds leading global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology, respiratory and hormonal therapeutics. Its products are sold in more than 160 countries, and reach more than 500 million patients. The company was founded in 1946 and is based in Princeton, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Cardiovascular Drugs 88
Infusions and Injectables 84
Immune Disorders Drugs 81
Antibiotics 74
Musculoskeletal Disorders Drugs 74
Infectious Diseases Drugs 72
Gastrointestinal Drugs 71
Generic Drugs 58
Biosimilars and Biosuperiors 57
Respiratory Drugs 56
Central Nervous System Drugs 54
Endocrine and Metabolic Disorders Drugs 54
Oncology Drugs 49
Analgesics 46
Pharmaceuticals 41
Animal Pharmaceuticals 37
Over the Counter (OTC) Drugs 37
Urological Disorders Drugs 33
Biopharmaceuticals 29
Hematological Drugs 29
Psoriasis Drugs 28
Immunosuppressive Drugs 27
Sexual and Reproductive Health Drugs 24
Breast Cancer Drugs 23
Optical Disorders Drugs 22
Mental Disorders Drugs 22
Lung Cancer Drugs 21
Anesthetic Drugs 20
Bronchitis Drugs 19
Inhalers and Nebulisers 15
Asthma Drugs 15
Pharmaceutical Intermediates 14
Leukemia Drugs 14
Transdermal and Transmucosal Drug Delivery 13
Drug Delivery 13
Dermatological Drugs 13
Acne Drugs 12
Colon Cancer Drugs 11
Pancreatic Cancer Drugs 11
Alzheimer's Disease Drugs 11
Anxiety Drugs 11
Addiction Disorders Drugs 10
Drugs by Therapeutic Area 10
Diabetes Drugs 10
Skin Cancer Drugs 10
Kidney Cancer Drugs 10
Pharmaceutical Manufacturing 10
Drug Discovery 9
Prostate Cancer Drugs 9
Ovarian Cancer Drugs 9
Liver and Kidney Disorders Drugs 8
Thyroid Cancer Drugs 8
Vitamins and Dietary Supplements 8
Schizophrenia Drugs 8
Allergy Drugs 7
Brain Cancer Drugs 5
Bladder Cancer Drugs 5
Cough and Cold Drugs 5
Clinical Trials 5
Anti-Obesity Drugs 4
HIV/AIDS Drugs 4
Cervical Cancer Drugs 3
Company Reports 2
Liver Cancer Drugs 2
Uterine Cancer Drugs 2
Pharmacoeconomics 1
Vaccines 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,002 Results (Page 30 of 51)
- Relevance
  Sort by

Osimertinib Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,455GBP

Germ Cell Tumor Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,455GBP

TNF Alpha Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,455GBP

Biologics CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
179 Pages
Global

From

€4192EUR$4,750USD£3,655GBP

Prader-Willi Syndrome Market Insight, Epidemiology and Market Forecast - 2034

 Report
July 2024
161 Pages
Global

From

€7016EUR$7,950USD£6,117GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Morphine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4192EUR$4,750USD£3,655GBP

Nasal Drop Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
108 Pages
Global

From

€3500EUR$4,248USD£3,158GBP

Osteoporosis - Pipeline Review, H2 2020

 Drug Pipelines
October 2020
375 Pages
Global

From

€1765EUR$2,000USD£1,539GBP

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2032

 Drug Pipelines
June 2025
150 Pages
Global

From

€3310EUR$3,750USD£2,886GBP

Atrophic Gastritis Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

 Report
January 2025
100 Pages
Global

From

€3500EUR$4,248USD£3,158GBP

Scopolamine Market

 Report
January 2024
200 Pages
Global

From

€3663EUR$4,150USD£3,193GBP

Omeprazole Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
100 Pages
Global

From

€3500EUR$4,248USD£3,158GBP

Clavulanate Potassium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
87 Pages
Global

From

€3500EUR$4,248USD£3,158GBP

Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

 Report
August 2023
1300 Pages
Global

From

€7855EUR$8,900USD£6,848GBP

Rituximab Biosimilars Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4368EUR$4,949USD£3,808GBP

Isosorbide Mononitrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
110 Pages
Global

From

€3500EUR$4,248USD£3,158GBP

Penicillin Drug Market Size, Share & Industry Trends Analysis Report By Source (Semisynthetic Penicillin and Natural Penicillin), By Spectrum of Activity, By Distribution Channel, By Route of Administration, By Regional Outlook and Forecast, 2023 - 2030

 Report
July 2023
284 Pages
Global

From

€3177EUR$3,600USD£2,770GBP

Axial Spondyloarthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
83 Pages
Global

From

€3500EUR$4,248USD£3,158GBP

Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029

 Report
February 2024
112 Pages
Global

From

€4192EUR$4,750USD£3,655GBP

Biosimilars - Global Strategic Business Report

 Report
April 2026
193 Pages
Global

From

€5163EUR$5,850USD£4,502GBP

1,002 Results (Page 30 of 51)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.